Butoconazole Articles
KV's 4th-qtr 2006 net income increases 16%
19 February 2007
KV and Richter Gedeon expand license deal
12 December 2005
KV Pharma licenses two women's products for Mexico
17 January 2005
Arrow to market KV's Gynazole in Australia and NZ
12 April 2004
Hugang to market KV's Gynazole-1 in China
1 March 2004
KV Pharma to sell thrush product in Brazil
15 July 2002
KV's Gynazole-1 targets $175M US market
15 June 2000
Roche Purchases KV Stock
7 April 1997
FDA Clears First One-Dose OTC Thrush Therapy
24 February 1997
Roche's 1996 Sales Ahead Of Expectations
27 January 1997
FDA Year-End Approvals Round-Up
8 January 1996
Showing 1-11 of 11 articles
- 1
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
